Literature DB >> 9291843

Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP)-3, IGF-I and IGF type 1 receptor mRNA levels, and serum IGF-I and IGFBP concentrations by growth hormone and IGF-I.

A B Lemmey1, J Glassford, H C Flick-Smith, J M Holly, J M Pell.   

Abstract

The aims of this investigation were (1) to examine IGF-binding protein-3 (IGFBP-3) mRNA levels in candidate tissues which might be important sources for blood IGFBP-3 (liver and skin) and in a target tissue for IGF-I action (skeletal muscle), and (2) to examine the effects of a single dose (500 micrograms) of GH or IGF-I on IGFBP-3 message levels in these tissues since temporal responses (4, 8 and 24 h after the single subcutaneous dose of peptide to GH-deficient dwarf rats) would indicate which peptide is the primary modulator of IGFBP-3 synthesis. Circulating IGF-I and IGFBP-3 concentrations were significantly increased (P < 0.05) by IGF-I and GH. GH treatment increased liver IGFBP-3 mRNA levels by 4 h (P < 0.001 over the 24 h) whereas IGF-I had no effect. Similarly, GH, but not IGF-I, increased muscle IGFBP-3 mRNA levels (P < 0.001 for the 24 h study period). However, both IGF-I and GH induced increases in skin IGFBP-3 mRNA abundance throughout the 24 h period (P < 0.001 and P < 0.01 respectively) and skin IGFBP-3 message abundance was greater that in the liver. Liver IGF-I mRNA levels were, as expected, increased after GH and tended to decrease after IGF-I treatment; muscle IGF-I mRNA was increased by GH (P < 0.001) and, interestingly, progressively increased by IGF-I (P < 0.05 for the 24 h period); skin IGF-I mRNA levels were unchanged by both peptides. The IGF-I induced increase in serum IGFBP-3 concentrations in the absence of an increase in hepatic IGFBP-3 mRNA levels and a paucity of liver IGF-I type 1 receptor mRNA imply that other sources of IGFBP-3 protein or synthesis must exist. The response of skin IGFBP-3 mRNA levels to both GH and IGF-I suggests that other cell types, such as fibroblast-derived cells, could be more important than the liver in the regulation of circulating reservoir IGFBP-3 in certain circumstances. In contrast to some current suggestions, the rapid and consistent GH-induced increase in IGFBP-3 message levels in all tissues studied implies that GH might have a direct function in the regulation of IGFBP-3 synthesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291843     DOI: 10.1677/joe.0.1540319

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  12 in total

Review 1.  Cellular actions of insulin-like growth factor binding proteins.

Authors:  R J Ferry; L E Katz; A Grimberg; P Cohen; S A Weinzimer
Journal:  Horm Metab Res       Date:  1999 Feb-Mar       Impact factor: 2.936

2.  Reprogramming the posttranslational code of SRC-3 confers a switch in mammalian systems biology.

Authors:  Brian York; Chundong Yu; Jørn V Sagen; Zhaoliang Liu; Bryan C Nikolai; Ray-Chang Wu; Milton Finegold; Jianming Xu; Bert W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

3.  The skin as an endocrine organ.

Authors:  Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2009-09

4.  Roles of α-linolenic acid on IGF-I secretion and GH/IGF system gene expression in porcine primary hepatocytes.

Authors:  Xin-Ling Fang; Gang Shu; Zhi-Qi Zhang; Song-Bo Wang; Xiao-Tong Zhu; Ping Gao; Qian-Yun Xi; Yong-Liang Zhang; Qing-Yan Jiang
Journal:  Mol Biol Rep       Date:  2012-10-07       Impact factor: 2.316

5.  The expression of insulin-like growth factor binding proteins in human hepatocellular carcinoma.

Authors:  Y Gong; L Cui; G Y Minuk
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

6.  Control of growth hormone receptor and insulin-like growth factor-I expression by cortisol in ovine fetal skeletal muscle.

Authors:  J Li; A J Forhead; M J Dauncey; R S Gilmour; A L Fowden
Journal:  J Physiol       Date:  2002-06-01       Impact factor: 5.182

7.  Muscle mass deficits are associated with bone mineral density in men with idiopathic vertebral fracture.

Authors:  J H Macdonald; S F Evans; M W J Davie; C A Sharp
Journal:  Osteoporos Int       Date:  2006-11-11       Impact factor: 4.507

Review 8.  Skin manifestations of growth hormone-induced diseases.

Authors:  Christina Kanaka-Gantenbein; Christina Kogia; Mohamed Badawy Abdel-Naser; George P Chrousos
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 9.  Regulation of gene expression by growth hormone.

Authors:  Peter Rotwein
Journal:  Mol Cell Endocrinol       Date:  2020-03-06       Impact factor: 4.102

10.  Muscle mechano growth factor is preferentially induced by growth hormone in growth hormone-deficient lit/lit mice.

Authors:  Keiji Iida; Emina Itoh; Dong-Sun Kim; Juan P del Rincon; Karen T Coschigano; John J Kopchick; Michael O Thorner
Journal:  J Physiol       Date:  2004-08-12       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.